Clinical and Translational Science Collaborative of Cleveland
Clinical and Translational Science Collaborative of Cleveland
批准号:
9093876
负责人:
MICHAEL W. KONSTAN
金额:
$222.31万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-17 至 2018-05-31
关键词:
AmericasChild health careCitiesClinicClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunitiesDatabasesDevelopmentDiagnosticDoctor of PhilosophyElectronic Health RecordElectronicsEvaluationFocus GroupsGoalsGrantHealthHealth PrioritiesHome environmentHumanInformaticsInstitutionInstitutional Review BoardsInstructionLaboratoriesMalignant NeoplasmsMedicalMedical centerMindNeedlesNeighborhoodsOhioPatientsPostdoctoral FellowResearchResearch InfrastructureResearch TrainingResource SharingResourcesSiteSupport SystemTestingTherapeuticTraining ProgramsTranslational ResearchTranslationsUnited States Department of Veterans AffairsUniversitiesUniversity Hospitalsbasecommunity partnershipdata sharingdiabeticdoctoral studenteducation researchimprovedmanoperationoptimismpractice-based research networkpre-doctoralprogramsprototypescreeningtherapeutic targettoolweb siteweb-based informatics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Clinical and Translational Science Collaborative (CTSC) of Cleveland is a collaborative venture among five Cleveland health institutions - Case Western Reserve University, the Cleveland Clinic, University Hospitals, MetroHealth Medical Center, and the Veterans Administration Medical Center, as well as community partners. CTSC achieved prior goals of uniting as a collaborative, developed informatics tools, resource sharing, and institutional commitments to enhance the collaborative. Consolidation and catalytic activities begun in the last grant period will be continued. Moreover, CTSC will continue rigorous evaluation of both its operations and progress toward larger goals. CTSC has set three new goals for the next grant period.' 1) Translation 1 research will be enhanced. Infrastructure in support of identification and structural determination of therapeutic targets, as well as high through put screening will be implemented. Support systems to assist in patient based research both recruitment and testing will be streamlined and strengthened. Critically, CTSC will create support systems to guide development of potential human therapeutics and diagnostics from discovery to use in man, 2) CTSC will improve health parameters in Cleveland, one of America's poorest and least healthy cities. Community Research Partnership Core is querying the community via neighborhood focus groups to determine their health priorities. At least one of these priorities, and others selected based on the strengths of our CTSC investigative community, will be targeted for special effort. One practice based research network has already succeeded in reducing HgbAlc in 27,000 diabetics in Cleveland by one percentage point in three years, raising optimism that this project can indeed move the needle. 3) CTSC interactions with the national CTSA community will increase. The initial focus of CTSC was inward, establishing connections and catalyzing change in our home institutions, but in the next grant period the CTSC will increase interactions around the consortium. A primary focus will be the Ohio Consortium of the three Ohio CTSAs (CTSC, Columbus, Cincinnati), which currently collaborate surrounding child health and cancer projects, and on the web site NetWellness, which has been expanded from simply providing unbiased medical information to include descriptions of clinical research and access to clinical trials. In the next grant period goals will include extending the CTSC IRB electronic hub for facilitated review to include the other CTSA sites, increasing project collaboration, and connecting patient databases via Explorys, a web based informatics tool utilizing the electronic health record.
期刊论文(189)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1056/nejmra1506330
发表时间:
2016-09-22
期刊:
The New England journal of medicine
影响因子:
--
作者:
[Lazaridis KN, LaRusso NF]
通讯作者:
LaRusso NF
In reply.
回复。
DOI:
10.3949/ccjm.81c.12002
发表时间:
2014
期刊:
Cleveland Clinic journal of medicine
影响因子:
6.1
作者:
[ChingSun,GraceE, Kashyap,SangeetaR, Nasr,Christian]
通讯作者:
Nasr,Christian
Clinical and Translational Science Collaborative of Cleveland
-
批准号:9978966
-
项目类别:
-
资助金额:$672.2万
-
财政年份:2018
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Research Career Development in Child Health
-
批准号:7994220
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2008
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Research Career Development in Child Health
-
批准号:8197139
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2008
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical and Translational Science Collaborative of Cleveland
-
批准号:9093875
-
项目类别:
-
资助金额:$977.48万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Clinical Studies
-
批准号:7288639
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2007
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PTC124 AS AN ORAL TREATMENT FOR NONSENSE-MUTATION-MEDIATED CYSTIC FIBROSIS
-
批准号:7378077
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2006
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
BIIL284BS IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS
-
批准号:7202776
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
ORAL THERACLEC-TOTAL IN CF PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
-
批准号:7202793
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
TOBRAMYCIN FOR INHALATION (TOBI) IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
-
批准号:7202765
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
BIIL284BS in adult and pediatric cystic fibrosis patients
-
批准号:6974994
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Oral TheraCLEC-Total in adult and pediatric subjects with cystic fibrosis
-
批准号:6974986
-
项目类别:
-
资助金额:$6.21万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Fat and protein absorption in cystic fibrosis pts with pancreatic insufficiency
-
批准号:6975001
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
Neutrophil imaging of the lung for characterizing pulmonary infection in CF pts
-
批准号:6974990
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2004
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6301071
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2000
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
LUNG SPECIFIC BIOEFFICACY OF ORAL DMP 777 IN ADULTS W/ CF
-
批准号:6305356
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
CPX (ORAL, MULTIDOSE) IN ADULTS W/ MILD TO MODERATELY SEVERE CYSTIC F
-
批准号:6305371
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6201835
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1999
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
CPX (ORAL, MULTIDOSE) IN ADULTS W/ MILD TO MODERATELY SEVERE CYSTIC F
-
批准号:6264431
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
PROLASTIN AEROSOL THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
-
批准号:6105187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
DMP777 IN ADULT PATIENTS 18 YRS OF AGE AND OLDER WITH CYSTIC FIBROSIS
-
批准号:6115324
-
项目类别:
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:MICHAEL W. KONSTAN
-
依托单位:
海外基金